Oncological Pathology and Bioinformatics (PO&B)

ONCOLOGY
OBJECTIUS

The Research Group on Oncological Pathology and Bioinformatics (PO&B) is a specific platform for research activities focused on cancer and digital image analysis and mathematical modeling.

RESPONSABLES
  • Dra. Marylène Lejeune

  • Dr. Carlos López Pablo

  • Presentation
  • Research lines
  • Dissemination
  • Group members
  • Publications
  • Projects
  • Contact

The PO&B team of the IRB CatSud, based at the Hospital de Tortosa Verge de la Cinta, has been working for more than 15 years on the prevention and advanced diagnosis of cancer. Led by Dra. Marylène Lejeune and Dr. Carlos López, the PO&B team is an interdisciplinary group that includes pathologists, oncologists, hematologists, biologists, biotechnologists and computer specialists, with strategic clinical and methodological skills for the development of the group’s research lines. During all these years, the group has had different projects financed jointly with national collaborators (Rovira i Virgili University [URV] of Tarragona; University of Castilla-La Mancha; Puerta del Mar University Hospital of Cádiz; University of Las Palmas de Gran Canary Islands) and international (Nalecz Institute of Biocybernetics and Biomedical Engineering in Warsaw, Poland; University of Caen, France).

The consolidated lines of research of the PO&B team focus on the study of the tumor microenvironment through digital image analysis and mathematical modeling. The immune response is one of the components of the tumor microenvironment that has been shown to play an important role in the evolution of cancer patients. Changes in the type and amount of immune cells in the tumor microenvironment have been related to differences in disease functionality. Our team has studied these changes through the development of new computer-assisted image analysis algorithms capable of providing more accurate and reproducible automated quantification of immune biomarkers with immunohistochemical and fluorescence staining.

The PO&B group has been recognized as a URV group since 2016, as an emerging group since 2009 and consolidated since 2014 by the Agency for the Management of University and Research Grants (AGAUR). Team members also coordinate the IRB CatSud’s cross-platform and support platform for histological, pathological, and digitization studies.

The group is working with the strategic goal of improving the administration of current cancer treatments and detecting new therapeutic targets in breast cancer and lymphomas to reduce the risk of relapse and improve patient survival. The group’s lines of research are as follows:

1) Study of biomarker patterns of the tumor microenvironment. This line of research aims to identify patterns of immune response of the tumor microenvironment and etiological, pathophysiological, and prognostic factors linked to models of neoplasia progression (breast cancer and lymphoproliferative syndromes). These objectives can help to understand the biological mechanisms involved in the resistance to chemotherapy and the obtaining of new therapeutic targets with the capacity to intervene, as well as the constitution of new key factors in the diagnosis, prognosis, and treatment of these patients.

2) Morphometry and applied computing. This line of research aims to develop and improve new computer aids for computer-assisted image analysis to allow a more accurate and reproducible automated quantification of biomarkers of tumor cells and host of the tumor microenvironment with immunohistochemical staining. and fluorescence.

3) Translational research in hematological diseases: evaluation of diagnostic protocols and treatments. This line of research aims to expand the existing prior knowledge of blood diseases, of new procedures suitable for their diagnosis, and, very especially, of new treatments that allow the cure or at least prolong the life of the people suffering from a hematological disease whether neoplastic or not.

4) Bioinformatics and artificial intelligence. The objective is to develop predictive models related to the survival and relapse of patients with breast cancer and lymphomas, using classical statistical methods and/or artificial intelligence, integrating clinical-pathological information, immune response and molecular markers.

5) Computational modeling. The objective is to computationally model the tumor microenvironment in breast cancer, both in the primary tumor and in the axillary lymph node, using agent-based models. These computational models will allow the simulation of the actions and interactions of immune populations and molecular markers, to see what effects they produce on the system as a whole.

    A modular deep learning pipeline for stromal TILs scoring in breast cancer H&E slides.

    Abdelazeez S, Ahmed F, Adalid L, Siemion K, Lopez C, Lejeune M, Rashwan H, Korzynska A. 01/08/2026

    AI-based framework pipeline for stromal tumor infiltrating lymphocytes quantification in H&E stained breast cancer histopathological images

    Abdelazeez, S, Fiorin, A, Della Mea, V, Adalid, L, Siemion, K, Lopez, C, Lejeune, M, Korzynska, A. 01/07/2026

    Towards Breast Tumor Aggressiveness Classification in Digital Mammograms Using Boundary-Aware Segmentation and Feature Analysis

    Khalid, A, Mursil, M, Okran, AM, Padro, JG, Pablo, CL, Puig, D, Rashwan, HA. 01/01/2026

    UWarp: A Whole Slide Image Registration Pipeline to Characterize Scanner-Induced Local Domain Shift

    Schieb, A, Hadjadji, B, Barrera, NFV, Mweze, DT, Derangère, V, Arnould, L, Ladoire, S, Lalande, A, Fiorin, A, Pablo, CL, Gallardo-Borràs, N, Abdelazeez, S, Della Mea, V, Korzynska, A, Vinçon, N, Morel, LO. 01/01/2026

    Influence of the Molecular Subtype-Dependent Immune Microenvironment of Metastatic Axillary Lymph Nodes on Breast Cancer Patient Outcomes.

    López C, Reverté L, Bosch Príncep R, Sauras E, Gallardo-Borràs N, Fischer-Carles A, Korzynska A, García-Rojo M, Bueno G, Roszkowiak L, Roso-LLorach A, Gras Navarro A, Llobera M, Mata D, Adalid Llansa L, Martínez-González S, Garcia-Fontgivell JF, Arenas M, Gómez J, Izuel JA, Baucells J, Lejeune M. 31/12/2025

    Cell populations in human breast cancers are molecularly and biologically distinct with age

    Parsons, A, Colón, ES, Manjunath, M, Zhang, HY, Chen, JL, Spasic, M, Koca, B, Kurt, BB, Freedman, RA, Mittendorf, EA, Swarbrick, A, van Galen, P, McAllister, SS. 01/12/2025

    Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group.

    Colbert SMC, Monson ET, Andreassen OA, Ayinde OO, Barr PB, Bejan CA, Ceja Z, Coon H, DiBlasi E, Edenberg HJ, Gelernter J, Hatoum A, Izotova A, Johnson EC, Kaufman EA, Kranzler HR, Koromina M, Lehto K, Myung W, Nurnberger JI Jr, Serretti A, Smoller JW, Stein MB, Zai CC, Erlangsen A, Gaine M, Martorell L, Sud R, Toma C, Bigdeli TB, Kimbrel NA, Ruderfer D, Docherty AR, Mann JJ, Mullins N. 01/12/2025

    Histological Hyperspectral Breast Cancer Recurrence Database (HistologyHSI-BC Recurrence)

    Quintana-Quintana, L, Sauras-Colon, E, Fiorin, A, Santana-Nunez, J, Ortega, S, Gallardo-Borràs, N, Fischer-Carles, A, Sánchez-Alcántara, T, Fabelo, H, Adalid-Llansa, L, Mata-Cano, D, Bosch-Príncep, R, Lejeune, M, Callico, GM, Lopez-Pablo, C. 28/11/2025

    Advancing breast cancer relapse prediction with radiomics and neural networks: a clinically interpretable framework.

    Khalid A, Mursil M, Pablo CL, Bosch R, Puig D, Rashwan HA. 15/09/2025

    Exploring the transcriptomic landscape of non-metastatic axillary lymph nodes as a prognostic factor in breast cancer

    Colón, ES, Badia-Cabré, J, Gallardo-Borràs, N, Fischer-Carles, A, Fiorin, A, Sánchez-Alcántara, T, Casanova-Ribes, J, Fábrega-Marcos, MA, Mata-Cano, D, Adalid-Llansa, L, Goyda, E, Masip-Bonet, A, Bosch-Príncep, R, Lejeune, M, López-Pablo, C. 01/09/2025

    Assessing tumour-infiltrating lymphocytes in breast cancer: depth variability across sections, observer agreement, and prognostic implications

    Gallardo-Borràs, N, Adalid-Llansa, L, Sauras-Colón, E, Mata-Cano, D, Goyda, E, Fiorin, A, Fischer-Carles, A, Sánchez-Alcantara, T, Masip-Bonet, A, Ballester-Navarro, M, Salvadó-Piñol, M, Bosch-Príncep, R, Lejeune, M, López-Pablo, C. 01/09/2025

    Dietary switch and intermittent fasting ameliorate the disrupted postprandial short-chain fatty acid response in diet-induced obese mice

    Ceperuelo-Mallafre, V, Rodríguez-Peña, MM, Badia, J, Villanueva-Carmona, T, Cedó, L, Marsal-Beltran, A, Benaiges, E, Núñez-Roa, C, Salmerón-Pelado, L, Osuna-Prieto, FJ, Bosch, R, Pellitero, S, Fernández-Veledo, S, Vendrell, J. 01/07/2025

    Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design

    Groen, K, Kuratli, R, Enkelmann, J, Fernbach, S, Wendel-Garcia, PD, Staiger, WI, Lejeune, M, Sauras-Colón, E, Roche-Campo, F, Filippidis, P, Rauch, A, Swiss HIV Cohort Study, Trkola, A, Günthard, HF, Kouyos, RD, Brugger, SD, Hale, BG. 20/03/2025

    Effectiveness of a Multicomponent Program for Fibromyalgia Patients in a Primary Care Setting (FIBROCARE Program): A Pragmatic Randomized Controlled Trial

    Angelats, RC, Gonçalves, AQ, Abellana, R, Carrasco-Querol, N, Corts, AP, Serra, GG, Benaiges, DG, Sol, MC, Anguera, IF, Jordana, SC, Baticón, BC, Escolies, GB, Reverté, MF, Vallés, NE, Pitarque, NB, Cavallé, MM, Suazo, NP, Bargalló, JE, Guerrero, MAL, Guerrero, CL, Acín, PP, Callarisa, IM, Baucells, J, Ciurana, AS, Fernández-Sáez, J, Llorca, MRD, Berenguera, A, Martín, CA. 01/01/2025

    Optimising Region of Interest Registration for Multiple-Tissue Whole Slide Images

    Fiorin, A, Llansa, LA, Goyda, E, Della Mea, V, Korzynska, A, Abdelazeez, S, Príncep, RB, Carles, AF, Borràs, NG, Lejeune, M, Cano, DM, Puig, D, Rashwan, HA, Colón, ES, de Uriarte, MRO, Calvet, LR, Pablo, CL. 01/01/2025

    Robust and Unified Semi-Supervised Unmixing of Hyperspectral Imaging for Linear and Multilinear Models

    Campos-Delgado, DU, Mendoza-Chavarría, JN, Gutierrez-Navarro, O, Quintana-Quintana, L, Leon, R, Ortega, S, Fabelo, H, López, C, Lejeune, M, Callico, GM. 01/01/2025

    Risk of developing neuroblastoma influenced by maternal stressful life events during pregnancy and congenital pathologies

    Benavent, N, Cañete, A, Moreno, L, Gros, L, Verdú-Amorós, J, Salinas, JA, Navarro, S, Alvaro, T, Carbonell-Asins, JA, Noguera, R, Tadeo, I. 02/12/2024

    Enhancing AI Research for Breast Cancer: A Comprehensive Review of Tumor-Infiltrating Lymphocyte Datasets

    Fiorin, A, Pablo, CL, Lejeune, M, Siraj, AH, Della Mea, V. 01/12/2024

    Diet-driven succinate production by intestinal microbiota stimulates GLP-1 secretion by colonic enteroendocrine cells via SUCNR1

    Villanueva-Carmona, T, Cedó, L, Núñez-Roa, C, Rodríguez-Peña, MM, Bosch, R, Koehler, JA, Rahimi, N, Santos-Hernández, M, Gribble, F, Reimann, F, Drucker, DJ, Fernández-Veledo, S, Vendrell, J. 01/09/2024

    Increased postprandial succinate levels are associated with hepatic gluconeogenesis regulation via SUCNR1

    Marsal-Beltran, A, Salmerón-Pelado, L, Ribas-Latre, A, Rodríguez-Peña, MM, Núñez-Roa, C, Repollés-de-Dalmau, M, Novoa, E, Nogueiras, R, Bosch, R, Vendrell, J, Ceperuelo-Mallafré, V, Fernández-Veledo, S. 01/09/2024

    Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

    Gonzalez-Lopez, TJ, Bermejo-Vega, N, Cardesa-Cabrera, R, Martinez-Robles, V, Aguilar-Monserrate, G, Perez-Segura, G, Domingo, A, Luis-Navarro, J, Lakhwani, S, Acedo, N, Lozano, ML, Bernat, S, Torres-Tienza, A, Ruano, A, Jarque, I, Galan, P, Benet, C, Marcellini, S, Jimenez-Barcenas, R, Martinez-Carballeira, D, De Miguel-Llorente, D, Perona-Blazquez, A, Gonzalez-Gasc, I, Lopez-Ansoar, E, Alonso-Alonso, JM, Bengochea-Casado, ML, Diaz-Galvez, FJ, Moreto, A, Moreno-Jimenez, G, Hernandez-Martin, R, de Cabo, E, Davila-Valls, J, Amalia, C, Pastoriza, C, Hermida-Fernandez, GJ, Garcia, C, Aguilar, C, Fernandez-Jimenez, D, Pozas-Manas, MA, Navas-Elorza, B, Castro, CLS, Lorenzo, A, Ortin, X, Garcia, M, Piernas, S, Diaz-Santa, J, Soto, I, Provan, D, Gabaldon, GGD. 08/08/2024

    SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes

    Sabadell-Basallote, J, Astiarraga, B, Castaño, C, Ejarque, M, Repollés-de-Dalmau, M, Quesada, I, Blanco, J, Núñez-Roa, C, Rodríguez-Peña, MM, Martínez, L, Jesus, DFD, Marroqui, L, Bosch, R, Montanya, E, Sureda, FX, Tura, A, Mari, A, Kulkarni, RN, Vendrell, J, Fernández-Veledo, S. 17/06/2024

    Ki67 as a prognostic factor in male breast cancer (male BC): Results from a large GEICAM Spanish cohort of male BC

    Urruticoechea, A, Martinez, P, Hernando, C, Recalde, S, Munoz, AS, Morales, D, Santisteban, M, Fernández, I, Del Barco, S, Zamora, E, Iranzo, V, Martos, T, Martinez, E, Novoa, SA, Modolell, A, Alonso, MG, García, E, Bueso, P, Llobera, M, Martinez-Jañez, N. 01/06/2024

    Prematurity and congenital malformations differ according to the type of pregestational diabetes

    Ballesteros, M, Guarque, A, Ingles, M, Vilanova, N, Lopez, M, Martin, L, Jane, M, Puerto, L, Martinez, M, De la Flor, M, Vendrell, J, Megia, A. 02/05/2024

    Changes in oxidative stress and the inflammatory system in breast cancer patients

    Avila, VDC, Franco, AJ, Capdevila, MC, Pablo, RG, Aguilar, JMJ, Casta , H, Mora, PA, Chac n, BAM, Benitez, G, Acosta, JC, Benavides, R, Troncho, CE, Engel, O, Parada, D, De la Flor, M, Jord , C, Mel , M, Repkova, J, Prat, MA. 01/05/2024

    Impact on weight loss and body composition of a food education intervention associated with liraglutide treatment to address obesity

    Sanchis, MD, Arribas, BV, Carrasco-Querol, N, Colón, ES, Sánchez-Juan, C. 01/05/2024

    Metabolic profiling of plasma and tissue in breast cancer patients: uncovering therapeutic response

    Jim nez-Franco, A, Calder n, D, Jim nez-Aguilar, J, Canela-Capdevila, M, Garc a-Pablo, R, Casta , H, Araguas, P, Malave, B, Acosta, JC, Benavides, R, Arquez, M, Casta o, F, Riu, F, De la Flor, M, Jord , C, Mel , M, Repkova, J, Amillano, K, Camps, J, Joven, J, Arenas, M. 01/05/2024

    Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase

    Peraire, J, García-Pardo, G, Chafino, S, Sánchez, A, Botero-Gallego, M, Olona, M, Espineira, S, Reverté, L, Skouridou, V, Peiró, OM, Gómez-Bertomeu, F, Vidal, F, O’ Sullivan, CK, Rull, A. 06/04/2024

    Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.

    Blanco, CM, Palomares, LD, Gonzálvez, CL, Muñoz, SP, Laguna, VM, Llansa, LA, Gómez, DG, Mejía, MM, Pinel, MA, Linares, CM, Padró, JG. 01/03/2024

    CD8+NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

    Hontecillas-Prieto, L, García-Domínguez, DJ, Palazón-Carrión, N, García-Sancho, AM, Nogales-Fernández, E, Jiménez-Cortegana, C, Sánchez-León, ML, Silva-Romeiro, S, Flores-Campos, R, Carnicero-González, F, Ríos-Herranz, E, de la Cruz-vicente, F, Rodríguez-García, G, Fernández-Alvarez, R, Martínez-Banaclocha, N, Gumà-Padrò, J, Gómez-Codina, J, Salar-Silvestre, A, Rodríguez-Abreu, D, Gálvez-Carvajal, L, Labrador, J, Guirado-Risueño, M, Provencio-Pulla, M, Sánchez-Beato, M, Marylene, L, Alvaro-Naranjo, T, Casanova-Espinosa, M, Rueda-Domínguez, A, Sánchez-Margalet, V, de la Cruz-merino, L. 26/02/2024

    Analysing Histology Hyperspectral Images: Does Tissue Thickness Matter?

    Santana-Nunez, J, Quintana-Quintana, L, Fabelo, H, Ortega, S, Sauras-Colon, E, Gallardo-Borras, N, Mata-Cano, D, Lopez-Pablo, C, Callico, GM. 01/01/2024

    Innovative Health and Social Integrated Care Model Effectiveness to Improve Quality Care for Chronic Patients: A Single Group Assignment Clinical Trial

    Gavaldà-Espelta, E, Lleixà-Fortuño, MD, Baucells-Lluis, J, Ferré-Ferraté, M, Tomàs-Navarro, B, Curto-Romeu, C, Lucas-Noll, J, Ariza, MP, Castro-Blanco, E, Sáez, JF, Martín, CA, Gonçalves, AQ, Ferré-Grau, C. 01/10/2023

    Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD

    Marsal-Beltran, A, Rodríguez-Castellano, A, Astiarraga, B, Calvo, E, Rada, P, Madeira, A, Rodríguez-Peña, MM, Llauradó, G, Núñez-Roa, C, Gómez-Santos, B, Maymó-Masip, E, Bosch, R, Frutos, MD, Moreno-Navarrete, JM, Ramos-Molina, B, Aspichueta, P, Joven, J, Fernández-Real, JM, Quera, JC, Valverde, AM, Pardo, A, Vendrell, J, Ceperuelo-Mallafré, V, Fernández-Veledo, S. 01/08/2023

    Lymphovascular Invasion and High Mitotic Count Are Associated With Increased Risk of Recurrence in Pleomorphic Dermal Sarcoma

    Benavent, MP, Ríos-Viñuela, E, Nagore, E, Monteagudo, C, Aguerralde, M, Cano, DM, Llombart, B, Serra-Guillén, C, Canales, IP, Requena, C, Sanmartín, O. 01/07/2023

    Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

    Lejeune, M, Reverté, L, Gallardo, N, Sauras, E, Bosch, R, Mata, D, Roso, A, Petit, A, Peg, V, Riu, F, Garcia-Fontgivell, J, Relea, F, Vieites, B, de la Cruz-merino, L, Arenas, M, Rodriguez, V, Galera, J, Korzynska, A, Plancoulaine, B, Alvaro, T, López, C. 01/07/2023

    Ischemic stroke and vascular risk factors in young and older adults. Community-based retrospective study (2011-2020)

    Reverté-Villarroya, S, Suñer-Soler, R, Sauras-Colón, E, Zaragoza-Brunet, J, Fernández-Sáez, J, Lopez-Espuela, F. 01/06/2023

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort

    Oñate, G, Pratcorona, M, Garrido, A, Artigas-Baleri, A, Bataller, A, Tormo, M, Arnan, M, Vives, S, Coll, R, Salamero, O, Vall-Llovera, F, Sampol, A, Garcia, A, Cervera, M, Avila, SG, Bargay, J, Ortín, X, Nomdedéu, JF, Esteve, J, Sierra, J. 05/05/2023

    Medication Adherence and Contraceptive Counseling

    de Molina-Fernandez, MI, Reyes-Martí, L, De la Flor-López, M, Aguarón-García, MJ, Roca-Biosca, A, Rubio-Rico, L, Torner, RDR, Valls-Fonayet, F. 03/05/2023

    Exploring the circulatory metabolic alterations in breast cancer patients

    Franco, AJ, Tomàs, ER, Lluis, CP, Vilafranca, HC, Gaya, GB, Araguas, P, Malave, B, Calderón, D, Acosta, JC, Arquez, M, Benavides, R, Riu, F, De la Flor, M, Jordà, C, Melé, M, Repkova, J, Sabater, S, Camps, J, Joven, J, Arenas, M. 01/05/2023

    IMPACT OF GERIATRIC ASSESSMENTAND SOMATIC MUTATIONS IN HIGH-RISK MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR ALO-HCST. CET-AZA-2016-1 2022 UPDATE. ON BEHALF OF THE CETLAM GROUP

    Amer, N, Cabezón, M, Xicoy, B, Garrido, A, Baena, N, Canet, M, Arnan, M, Arenillas, L, Coll, R, Ortin, X, Diaz, M, Talarn, C, García-Caro, M, Zamora, L, Bargay, J. 01/05/2023

    SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression

    Villanueva-Carmona, T, Cedó, L, Madeira, A, Ceperuelo-Mallafré, V, Rodríguez-Peña, MM, Núñez-Roa, C, Maymó-Masip, E, Repollés-de-Dalmau, M, Badia, J, Keiran, N, Mirasierra, M, Pimenta-Lopes, C, Sabadell-Basallote, J, Bosch, R, Caubet, L, Escolà-Gil, JC, Fernández-Real, JM, Vilarrasa, N, Ventura, F, Vallejo, M, Vendrell, J, Fernández-Veledo, S. 04/04/2023

    Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies

    Oliveira, AC, Roncero, JM, Ferrá, C, Do Nascimento, J, Rodriguez-Luaces, M, Encuentra, M, Domingo-Domenech, E, López, P, Gallardo, D, Ribera, JM, Sarrá, J, Sureda, A, González-Barca, E. 01/03/2023

    Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response

    Lejeune, M, Reverté, L, Sauras, E, Gallardo, N, Bosch, R, Roso, A, Petit, A, Peg, V, Riu, F, García-Fontgivell, J, Ibáñez, J, Relea, F, Vieites, B, Bor, C, de la Cruz-Merino, L, Arenas, M, Rodriguez, V, Galera, J, Korzynska, A, Belhomme, P, Plancoulaine, B, Alvaro, T, López, C. 01/02/2023

    YOLOX-based Framework for Nuclei Detection on Whole-Slide Histopathological RGB and Hyperspectral Images

    Vega, C, Quintana, L, Ortega, S, Fabelo, H, Sauras, E, Gallardo, N, Mata, D, Lejeune, M, Lopez, C, Callico, GM. 01/01/2023

    Chromoblastomycosis due to Cladophialophora immunda: An emerging pathogen in immunocompromised patients?

    Abadías-Granado, I, Gómez-Mateo, MC, Stchigel, AM, López, C. 01/01/2023

    MIDOSTAURIN PLUS INTENSIVE CHEMO AS FRONT LINE IN FLT3 MUTATED AML. INTERIM ANALYSIS OF THE MDA-AML-2018-06 RWE STUDY

    De la Fuente, A, Beya, MD, Beneit, P, Fernandez, A, Arnan, M, Garrido, A, Polo, SV, Fortes, MG, Sampol, A, Labrador, J, Guinon, AG, Gil, C, Vall-LLovera, F, Olave, M, Ortin, X, Salamero, O, Cervera, M, Boyero, RG, Serrano, J, Tormo, M. 01/02/2023

    Stressor Factors for Spanish Nursing Students in a Pandemic Context: An Observational Pilot Survey

    Reverté-Villarroya, S, Gil-Mateu, E, Sauras-Colón, E, Barceló-Prats, J, Albacar-Riobóo, N, Ortega, L. 01/12/2022

    Vascular Risk Factors in Ischemic Stroke Survivors: A Retrospective Study in Catalonia, Spain

    Reverté-Villarroya, S, Suñer-Soler, R, Zaragoza-Brunet, J, Martín-Ozaeta, G, Esteve-Belloch, P, Payo-Froiz, I, Sauras-Colón, E, Lopez-Espuela, F. 01/11/2022

    Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma

    Bagué, S, León, X, Terra, X, Lejeune, M, Camacho, M, Avilés-Jurado, FX. 01/11/2022

    Rate of effect of surgical margins after breast conserving surgery and estimation of direct costs

    De la Flor, M, Delgado, C, Martínez, S, Arenas, M, Gómez, M, Reig, R. 01/11/2022

    Midostaurin maintenance vs ALLO SCT vs W&W in flt3 mutated AML. A "real life" multicenter study

    de la Fuente, A, Beya, MD, Beneit, P, Fernandez, A, Arnan, M, Garrido, A, Vives-Polo, S, Fortes, MG, Sampol, A, Labrador, J, Guinon, AG, Gil, C, Burgues, JB, Rubio, MTO, Amigo, ML, Ortin, X, Cervera, M, Estevez, M, Lopez, AD, Serrano, J, Tormo, M. 01/11/2022

    Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn's Disease

    Boronat-Toscano, A, Monfort-Ferré, D, Menacho, M, Caro, A, Bosch, R, Espina, B, Algaba-Chueca, F, Saera-Vila, A, Moliné, A, Marti, M, Espin, E, Millan, M, Serena, C. 01/10/2022

    Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

    Ceperuelo-Mallafré, V, Reverté, L, Peraire, J, Madeira, A, Maymó-Masip, E, López-Dupla, M, Gutierrez-Valencia, A, Ruiz-Mateos, E, Buzón, MJ, Jorba, R, Vendrell, J, Auguet, T, Olona, M, Vidal, F, Rull, A, Fernández-Veledo, S. 14/09/2022

    Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis

    Palazón-Carrión, N, García-Sancho, AM, Nogales-Fernández, E, Jiménez-Cortegana, C, Carnicero-González, F, Ríos-Herranz, E, de la Cruz-Vicente, F, Rodríguez-García, G, Fernández-Alvarez, R, Martínez-Banaclocha, N, Gumà-Padrò, J, Gómez-Codina, J, Salar-Silvestre, A, Rodríguez-Abreu, D, Gálvez-Carvajal, L, Labrador, J, Guirado-Risueño, M, García-Domínguez, DJ, Hontecillas-Prieto, L, Espejo-García, P, Fernández-Román, I, Provencio-Pulla, M, Sánchez-Beato, M, Navarro, M, Marylene, L, Alvaro-Naranjo, T, Casanova-Espinosa, M, Sánchez-Margalet, V, Rueda-Domínguez, A, de la Cruz-Merino, L. 01/09/2022

    CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients

    López, C, Bosch, R, Korzynska, A, García-Rojo, M, Bueno, G, García-Fontgivell, JF, González, SM, Navarro, AG, Colón, ES, Ribes, JC, Roszkowiak, L, Mata, D, Arenas, M, Gómez, J, Roso, A, Berenguer, M, Reverté-Villarroya, S, Llobera, M, Baucells, J, Lejeune, M. 01/07/2022

    The complexity of cancer immunotherapy illustrated through skin tumors

    Vieco-Martí, I, López-Carrasco, A, de la Cruz-Merino, L, Noguera, R, Naranjo, TA. 01/06/2022

    DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results

    Temprana-Salvador, J, López-García, P, Vives, JC, de Haro, L, Ballesta, E, Abusleme, MR, Arrufat, M, Marques, F, Casas, JR, Gallego, C, Pons, L, Mate, JL, Fernández, PL, López-Bonet, E, Bosch, R, Martínez, S, Cajal, SRY, Matias-Guiu, X. 01/04/2022

    VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis

    Pàmies, A, Ferràs, P, Bellaubí-Pallarés, N, Giménez, T, Raventós, A, Colobran, R. 02/03/2022

    Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome

    Perpiñan, C, Bertran, L, Terra, X, Aguilar, C, Binetti, J, Lopez-Dupla, M, Rull, A, Reverté, L, Yeregui, E, Gómez-Bertomeu, F, Peraire, J, Auguet, T. 01/03/2022

    Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy

    Yeregui, E, Masip, J, Viladés, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, García-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Martí, A, Reverté, L, Gómez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. 01/02/2022

    Multidisciplinary rehabilitation treatments for patients with fibromyalgia: a systematic review

    Llàdser, AN, Montesó-Curto, P, López, C, Rosselló, L, Lear, S, Toussaint, L, Casadó-Martín, LC. 01/02/2022

    Fetuin-A, inter-a-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

    Reverté, L, Yeregui, E, Olona, M, Gutiérrez-Valencia, A, Buzón, MJ, Martí, A, Gómez-Bertomeu, F, Auguet, T, López-Cortés, LF, Burgos, J, Benavent-Bofill, C, Boqué, C, García-Pardo, G, Ruiz-Mateos, E, Mestre, MT, Vidal, F, Viladés, C, Peraire, J, Rull, A. 01/01/2022

    In the use of Artificial Intelligence and Hyperspectral Imaging in Digital Pathology for Breast Cancer Cell Identification

    Quintana, L, Ortega, S, Leon, R, Fabelo, H, Balea-Fernández, FJ, Sauras, E, Lejeune, M, Bosch, R, Lopez, C, Callico, GM. 01/01/2022

    Press realeses

  • Title: A COMPREHENSIVE CAD SYSTEM BASED ON RADIOLOGIC- AND PATHOLOGIC-IMAGE BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF BREAST CANCER RELAPSE (BOSOMSHIELD) – PV22039S

    Funding entity: COMMISSION OF THE EUROPEAN COMMUNITIES

    Duration: 2022-2026

    Principal Investigator: LOPEZ PABLO, CARLOS

  • Title: 2021 LLAV 00051 AJUTS D’INDUSTRIA DEL CONEIXEMENT PER A L'ANY 2021. MODALITAT A. AJUTS LLAVOR. IMPRESSIO DE MOTLLES EN 3D PER ANALISIS HISTOLOGICS. ACRONYM: MOTLLES 3D – PV22089S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2022-2023

    Principal Investigator: LOPEZ PABLO, CARLOS

  • Title: TED2021-130081B-C22 PROYECTOS DE TRANSICION ECOLOGICA Y TRANSICION DIGITAL 2021 – PV22145S

    Funding entity: MINISTERIO DE CIENCIA Y TECNOLOGIA

    Duration: 2022-2025

    Principal Investigator: LOPEZ PABLO, CARLOS

  • Title: 2021 SGR 00319 GRUP DE RECERCA SONSOLIDAT (GRC) OPCIO RECONEIXEMENT SENSE FINANÇAMENT (VALIDACIO TECNICA) IISPV – PV23059S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2022-2025

    Principal Investigator: LEJEUNE, MARYLENE

  • Title: 2023 PROD 00085 AJUTS PRODUCTE MOTLLES EMMA CARLOS LOPEZ – PV24005S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2024-2025

    Principal Investigator: LOPEZ PABLO, CARLOS

  • Title: 13TH GINJOL INSTITUCIO CERCA – TMAtech Mold Codi 2024-13-017 (DR CARLOS LOPEZ) – PV24147S

    Funding entity: FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA

    Duration: 2025-2025

    Principal Investigator: LOPEZ PABLO, CARLOS

  • Title: CINQUENA EDICIO PREMIS FET A CATALUNYA – PV25178S

    Funding entity: ASSOCIACIO NOUS EMPRESARIS I EMPRENEDORS DE CATALUNYA NEEC

    Duration: 2025-2026

    Principal Investigator: LOPEZ PABLO, CARLOS

Membres De L’equip